These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7975830)

  • 1. Adaptive acid tolerance response by Salmonella typhi and candidate live oral typhoid vaccine strains.
    Hone DM; Harris AM; Levine MM
    Vaccine; 1994 Aug; 12(10):895-8. PubMed ID: 7975830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
    Tacket CO; Levine MM
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.
    Tacket CO; Hone DM; Curtiss R; Kelly SM; Losonsky G; Guers L; Harris AM; Edelman R; Levine MM
    Infect Immun; 1992 Feb; 60(2):536-41. PubMed ID: 1730487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.
    Salerno-Gonçalves R; Wyant TL; Pasetti MF; Fernandez-Viña M; Tacket CO; Levine MM; Sztein MB
    J Immunol; 2003 Mar; 170(5):2734-41. PubMed ID: 12594304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.
    Chatfield SN; Fairweather N; Charles I; Pickard D; Levine M; Hone D; Posada M; Strugnell RA; Dougan G
    Vaccine; 1992; 10(1):53-60. PubMed ID: 1311488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
    Levine MM; Hone D; Tacket C; Ferreccio C; Cryz S
    Res Microbiol; 1990; 141(7-8):807-16. PubMed ID: 2101470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
    Wang JY; Pasetti MF; Noriega FR; Anderson RJ; Wasserman SS; Galen JE; Sztein MB; Levine MM
    Infect Immun; 2001 Aug; 69(8):4734-41. PubMed ID: 11447145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers.
    Kirkpatrick BD; McKenzie R; O'Neill JP; Larsson CJ; Bourgeois AL; Shimko J; Bentley M; Makin J; Chatfield S; Hindle Z; Fidler C; Robinson BE; Ventrone CH; Bansal N; Carpenter CM; Kutzko D; Hamlet S; LaPointe C; Taylor DN
    Vaccine; 2006 Jan; 24(2):116-23. PubMed ID: 16140433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA.
    Lowe DC; Savidge TC; Pickard D; Eckmann L; Kagnoff MF; Dougan G; Chatfield SN
    Infect Immun; 1999 Feb; 67(2):700-7. PubMed ID: 9916080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of delta aroA his delta pur strains of Salmonella typhi.
    Edwards MF; Stocker BA
    J Bacteriol; 1988 Sep; 170(9):3991-5. PubMed ID: 2842296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Live Attenuated Bivalent Oral Vaccine Against Shigella sonnei Shigellosis and Typhoid Fever.
    Wu Y; Chakravarty S; Li M; Wai TT; Hoffman SL; Sim BK
    J Infect Dis; 2017 Jan; 215(2):259-268. PubMed ID: 27803169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
    Teng J; Rui X; Zhang Y; Zhang Z; Su G
    Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PhoP virulence regulon and live oral Salmonella vaccines.
    Miller SI; Loomis WP; Alpuche-Aranda C; Behlau I; Hohmann E
    Vaccine; 1993; 11(2):122-5. PubMed ID: 8438611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.
    Wahid R; Fresnay S; Levine MM; Sztein MB
    Clin Immunol; 2016 Dec; 173():87-95. PubMed ID: 27634430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations.
    Kirkpatrick BD; Tenney KM; Larsson CJ; O'Neill JP; Ventrone C; Bentley M; Upton A; Hindle Z; Fidler C; Kutzko D; Holdridge R; Lapointe C; Hamlet S; Chatfield SN
    J Infect Dis; 2005 Aug; 192(3):360-6. PubMed ID: 15995948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.